{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:52:56Z","timestamp":1781481176873,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49038-5","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:17:36Z","timestamp":1776748656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["VCAN promotes the progression and recurrence of esophageal squamous cell carcinoma by remodeling the tumor microenvironment"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhipeng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"49038_CR1","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/mc.23913","volume":"64","author":"Y Ding","year":"2025","unstructured":"Ding, Y. et al. SRPK1 Activation Facilitates Gli3(S664) Phosphorylation and Promotes Metastasis in Esophageal Squamous Cell Carcinoma. Mol. Carcinog. 64, 1168\u20131181. https:\/\/doi.org\/10.1002\/mc.23913 (2025).","journal-title":"Mol. Carcinog."},{"key":"49038_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00018-022-04131-6","volume":"79","author":"M Lohan-Code\u00e7o","year":"2022","unstructured":"Lohan-Code\u00e7o, M. et al. Molecular mechanisms associated with chemoresistance in esophageal cancer. Cell. Mol. Life Sci. 79, 116. https:\/\/doi.org\/10.1007\/s00018-022-04131-6 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"49038_CR3","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1038\/s41467-020-20019-0","volume":"11","author":"Y Zheng","year":"2020","unstructured":"Zheng, Y. et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat. Commun. 11, 6268. https:\/\/doi.org\/10.1038\/s41467-020-20019-0 (2020).","journal-title":"Nat. Commun."},{"key":"49038_CR4","doi-asserted-by":"publisher","first-page":"101954","DOI":"10.1016\/j.bpg.2024.101954","volume":"72","author":"DV Peristeri","year":"2024","unstructured":"Peristeri, D. V., Tarazi, M., Casey, P., Powell, A. & Sultan, J. Effect of the immune microenvironment on prognosis in oesophageal adenocarcinoma. Best Pract. Res. Clin. Gastroenterol. 72, 101954. https:\/\/doi.org\/10.1016\/j.bpg.2024.101954 (2024).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"49038_CR5","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1111\/cas.16203","volume":"115","author":"K Sugawara","year":"2024","unstructured":"Sugawara, K. et al. Impacts of tumor microenvironment during neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma. Cancer Sci. 115, 2819\u20132830. https:\/\/doi.org\/10.1111\/cas.16203 (2024).","journal-title":"Cancer Sci."},{"key":"49038_CR6","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.3748\/wjg.v30.i16.2195","volume":"30","author":"XJ Zhang","year":"2024","unstructured":"Zhang, X. J. et al. Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer. World J. Gastroenterol. 30, 2195\u20132208. https:\/\/doi.org\/10.3748\/wjg.v30.i16.2195 (2024).","journal-title":"World J. Gastroenterol."},{"key":"49038_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cancergen.2025.06.010","volume":"296\u2013297","author":"D Zeng","year":"2025","unstructured":"Zeng, D., Ye, S., Yin, W., Lian, D. & Zhou, S. Influence of IL-38 as a novel biomarker on the pathophysiological processes of esophageal cancer. Cancer Genet. 296\u2013297, 117\u2013124. https:\/\/doi.org\/10.1016\/j.cancergen.2025.06.010 (2025).","journal-title":"Cancer Genet."},{"key":"49038_CR8","doi-asserted-by":"publisher","first-page":"1689468","DOI":"10.3389\/fimmu.2025.1689468","volume":"16","author":"H Gao","year":"2025","unstructured":"Gao, H. et al. APE1 mediates chemoresistance in esophageal squamous cell carcinoma by remodeling the immunosuppressive microenvironment. Front. Immunol. 16, 1689468. https:\/\/doi.org\/10.3389\/fimmu.2025.1689468 (2025).","journal-title":"Front. Immunol."},{"key":"49038_CR9","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1097\/js9.0000000000002589","volume":"111","author":"J Zhong","year":"2025","unstructured":"Zhong, J. et al. PTGDS deficiency as a driver of M2 macrophage polarization and immunosuppressive microenvironment in esophageal squamous cell carcinoma: an experimental study. Int. J. Surg. 111, 5058\u20135070. https:\/\/doi.org\/10.1097\/js9.0000000000002589 (2025).","journal-title":"Int. J. Surg."},{"key":"49038_CR10","doi-asserted-by":"publisher","first-page":"16696","DOI":"10.1038\/s41598-021-96274-y","volume":"11","author":"Z Feng","year":"2021","unstructured":"Feng, Z. et al. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma. Sci. Rep. 11, 16696. https:\/\/doi.org\/10.1038\/s41598-021-96274-y (2021).","journal-title":"Sci. Rep."},{"key":"49038_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1158\/1078-0432.Ccr-23-0562","volume":"30","author":"N Zila","year":"2024","unstructured":"Zila, N. et al. Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy. Clin. Cancer Res. 30, 159\u2013175. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-0562 (2024).","journal-title":"Clin. Cancer Res."},{"key":"49038_CR12","doi-asserted-by":"publisher","first-page":"e0323665","DOI":"10.1371\/journal.pone.0323665","volume":"20","author":"BU Haq","year":"2025","unstructured":"Haq, B. U. et al. Unravelling the therapeutic potential of dual TGF\u03b2-1 and CXCR4 inhibition in breast cancer using computational strategies. PLoS One. 20, e0323665. https:\/\/doi.org\/10.1371\/journal.pone.0323665 (2025).","journal-title":"PLoS One"},{"key":"49038_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/cancers17091435","volume":"17","author":"PB Emmerich","year":"2025","unstructured":"Emmerich, P. B. et al. Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8(+) T Cells in Breast Cancer. Cancers (Basel). 17, 1435. https:\/\/doi.org\/10.3390\/cancers17091435 (2025).","journal-title":"Cancers (Basel)"},{"key":"49038_CR14","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/ijms27052409","volume":"27","author":"S Zhang","year":"2026","unstructured":"Zhang, S. et al. Role and Mechanism of BRIP1 in Anoikis Resistance of Gastric Cancer. Int. J. Mol. Sci. 27, 2409. https:\/\/doi.org\/10.3390\/ijms27052409 (2026).","journal-title":"Int. J. Mol. Sci."},{"key":"49038_CR15","doi-asserted-by":"publisher","first-page":"e70600","DOI":"10.1002\/cam4.70600","volume":"14","author":"W Zang","year":"2025","unstructured":"Zang, W. et al. The MIR181A2HG\/miR-5680\/VCAN-CD44 Axis Regulates Gastric Cancer Lymph Node Metastasis by Promoting M2 Macrophage Polarization. Cancer Med. 14, e70600. https:\/\/doi.org\/10.1002\/cam4.70600 (2025).","journal-title":"Cancer Med."},{"key":"49038_CR16","doi-asserted-by":"publisher","first-page":"1280943","DOI":"10.3389\/fonc.2023.1280943","volume":"13","author":"W Lautert-Dutra","year":"2023","unstructured":"Lautert-Dutra, W. et al. Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence. Front. Oncol. 13, 1280943. https:\/\/doi.org\/10.3389\/fonc.2023.1280943 (2023).","journal-title":"Front. Oncol."},{"key":"49038_CR17","doi-asserted-by":"publisher","first-page":"1501906","DOI":"10.3389\/fnins.2024.1501906","volume":"18","author":"R Wei","year":"2024","unstructured":"Wei, R. et al. VCAN in the extracellular matrix drives glioma recurrence by enhancing cell proliferation and migration. Front. Neurosci. 18, 1501906. https:\/\/doi.org\/10.3389\/fnins.2024.1501906 (2024).","journal-title":"Front. Neurosci."},{"key":"49038_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13046-024-03200-x","volume":"43","author":"G Li","year":"2024","unstructured":"Li, G. et al. NAT10\/ac4C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction. J. Exp. Clin. Cancer Res. 43, 278. https:\/\/doi.org\/10.1186\/s13046-024-03200-x (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"49038_CR19","doi-asserted-by":"publisher","first-page":"e2203573","DOI":"10.1002\/advs.202203573","volume":"10","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-Mediated GSK3\u03b2\/\u03b2-Catenin Signaling. Adv. Sci. (Weinh). 10, e2203573. https:\/\/doi.org\/10.1002\/advs.202203573 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"key":"49038_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12967-023-04303-3","volume":"21","author":"Q Ping","year":"2023","unstructured":"Ping, Q. et al. TGF-\u03b21 dominates stromal fibroblast-mediated EMT via the FAP\/VCAN axis in bladder cancer cells. J. Transl Med. 21, 475. https:\/\/doi.org\/10.1186\/s12967-023-04303-3 (2023).","journal-title":"J. Transl Med."},{"key":"49038_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12885-023-11428-7","volume":"23","author":"A Amin","year":"2023","unstructured":"Amin, A. et al. Dissection of paracrine\/autocrine interplay in lung tumor microenvironment mimicking cancer cell-monocyte co-culture models reveals proteins that promote inflammation and metastasis. BMC Cancer. 23, 926. https:\/\/doi.org\/10.1186\/s12885-023-11428-7 (2023).","journal-title":"BMC Cancer"},{"key":"49038_CR22","doi-asserted-by":"publisher","first-page":"e71349","DOI":"10.1096\/fj.202502979R","volume":"40","author":"B Hu","year":"2026","unstructured":"Hu, B. et al. Bulk Sequencing Combined With Single-Cell Sequencing Identifies High Expression of VCAN in Fibroblasts Promoting the Progression of High-Stemness Gastric Adenocarcinoma Cells. Faseb j. 40, e71349. https:\/\/doi.org\/10.1096\/fj.202502979R (2026).","journal-title":"Faseb j."},{"key":"49038_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1186\/s12967-025-06865-w","volume":"23","author":"S Chen","year":"2025","unstructured":"Chen, S. et al. The CTSZ-TRA2A-IL32 axis defines a targetable macrophage-dependent pathway in metastatic prostate cancer. J. Transl Med. 23, 865. https:\/\/doi.org\/10.1186\/s12967-025-06865-w (2025).","journal-title":"J. Transl Med."},{"key":"49038_CR24","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.4049\/jimmunol.1700529","volume":"199","author":"C Hope","year":"2017","unstructured":"Hope, C. et al. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer. J. Immunol. 199, 1933\u20131941. https:\/\/doi.org\/10.4049\/jimmunol.1700529 (2017).","journal-title":"J. Immunol."},{"key":"49038_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41698-026-01292-6","volume":"10","author":"L Heij","year":"2026","unstructured":"Heij, L. et al. Multimodal single-cell profiling reveals crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients. NPJ Precis Oncol. 10, 105. https:\/\/doi.org\/10.1038\/s41698-026-01292-6 (2026).","journal-title":"NPJ Precis Oncol."},{"key":"49038_CR26","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.21037\/tlcr-2025-244","volume":"14","author":"M Xiao","year":"2025","unstructured":"Xiao, M. et al. Single-cell and spatial transcriptomics profile the interaction of SPP1(+) macrophages and FAP(+) fibroblasts in non-small cell lung cancer. Transl Lung Cancer Res. 14, 2646\u20132669. https:\/\/doi.org\/10.21037\/tlcr-2025-244 (2025).","journal-title":"Transl Lung Cancer Res."},{"key":"49038_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbrc.2022.12.086","volume":"643","author":"W Song","year":"2023","unstructured":"Song, W., Qin, L., Chen, Y., Chen, J. & Wei, L. Single-cell transcriptome analysis identifies Versican(+) myofibroblast as a hallmark for thoracic aortic aneurysm marked by activation of PI3K-AKT signaling pathway. Biochem. Biophys. Res. Commun. 643, 175\u2013185. https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.086 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"49038_CR28","doi-asserted-by":"publisher","first-page":"1625208","DOI":"10.3389\/fimmu.2025.1625208","volume":"16","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Tumor-derived SEMA7A regulates fatty acid oxidation in the tumor-associated macrophages to promote the progression of non-small cell lung cancer. Front. Immunol. 16, 1625208. https:\/\/doi.org\/10.3389\/fimmu.2025.1625208 (2025).","journal-title":"Front. Immunol."},{"key":"49038_CR29","doi-asserted-by":"publisher","unstructured":"Song, N. et al. ITGB1 Regulates Triple-Negative Breast Cancer Development by Modulating the Tumor Microenvironment. Adv. Sci. (Weinh). e13672. https:\/\/doi.org\/10.1002\/advs.202513672 (2026).","DOI":"10.1002\/advs.202513672"},{"key":"49038_CR30","doi-asserted-by":"publisher","first-page":"1640450","DOI":"10.3389\/fimmu.2026.1640450","volume":"17","author":"M Xue","year":"2026","unstructured":"Xue, M. et al. GCDCA promotes hepatocellular carcinoma progression through S1PR2\/PI3K\/AKT-mediated polarization of M2-type macrophages. Front. Immunol. 17, 1640450. https:\/\/doi.org\/10.3389\/fimmu.2026.1640450 (2026).","journal-title":"Front. Immunol."},{"key":"49038_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41416-025-03326-5","volume":"134","author":"DB Shi","year":"2026","unstructured":"Shi, D. B. et al. INHBA, regulated by C\/EBP\u03b2, induces M2 macrophage polarization to promote tumor metastasis and growth via activating the PI3K\/AKT pathway in gastric cancer. Br. J. Cancer. 134, 1031\u20131041. https:\/\/doi.org\/10.1038\/s41416-025-03326-5 (2026).","journal-title":"Br. J. Cancer"},{"key":"49038_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2025.08.003","volume":"298\u2013299","author":"L Jahangiri","year":"2025","unstructured":"Jahangiri, L. The impact of extracellular vesicles on breast cancer metastasis and therapeutics: genetic considerations. Cancer Genet. 298\u2013299, 1\u20139. https:\/\/doi.org\/10.1016\/j.cancergen.2025.08.003 (2025).","journal-title":"Cancer Genet."},{"key":"49038_CR33","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/ph17070951","volume":"17","author":"X Pei","year":"2024","unstructured":"Pei, X. et al. Cancer Cell Secreted Legumain Promotes Gastric Cancer Resistance to Anti-PD-1 Immunotherapy by Enhancing Macrophage M2 Polarization. Pharmaceuticals (Basel). 17, 951. https:\/\/doi.org\/10.3390\/ph17070951 (2024).","journal-title":"Pharmaceuticals (Basel)"},{"key":"49038_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12935-024-03453-8","volume":"24","author":"P Su","year":"2024","unstructured":"Su, P. et al. Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1\/JAK2\/STAT3 pathway in gastric cancer. Cancer Cell. Int. 24, 287. https:\/\/doi.org\/10.1186\/s12935-024-03453-8 (2024).","journal-title":"Cancer Cell. Int."},{"key":"49038_CR35","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.3390\/ijms24087486","volume":"24","author":"HL Luo","year":"2023","unstructured":"Luo, H. L. et al. VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma. Int. J. Mol. Sci. 24, 7486. https:\/\/doi.org\/10.3390\/ijms24087486 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"49038_CR36","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/carcin\/bgw069","volume":"37","author":"S Chida","year":"2016","unstructured":"Chida, S. et al. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer. Carcinogenesis 37, 878\u2013887. https:\/\/doi.org\/10.1093\/carcin\/bgw069 (2016).","journal-title":"Carcinogenesis"},{"key":"49038_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu, H., Li, Y., Karsidag, M., Tu, T. & Wang, P. Technical and Biological Biases in Bulk Transcriptomic Data Mining for Cancer Research. J. Cancer. 16, 34\u201343. https:\/\/doi.org\/10.7150\/jca.100922 (2025).","journal-title":"J. Cancer"},{"key":"49038_CR38","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.genrep.2024.102042","volume":"37","author":"H Liu","year":"2024","unstructured":"Liu, H., Guo, Z. & Wang, P. Genetic expression in cancer research: Challenges and complexity. Gene Rep. 37, 102042. https:\/\/doi.org\/10.1016\/j.genrep.2024.102042 (2024).","journal-title":"Gene Rep."},{"key":"49038_CR39","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/cso2.70001","volume":"4","author":"H Liu","year":"2025","unstructured":"Liu, H. & Yang, Z. Time Management and Personal Efficiency in the Age of Computational and Systems Oncology. Comput. Syst. Oncol. 4, e70001. https:\/\/doi.org\/10.1002\/cso2.70001 (2025).","journal-title":"Comput. Syst. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49038-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49038-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:19:27Z","timestamp":1781479167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49038-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49038-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experimental procedures were approved by the Laboratory Animal Ethics Committee of Lai\u2019di Biomedical Research Institute (Guangdong) Co., LTD (Approval number: LDSW2025050-2), and were carried out in accordance with the ARRIVE guidelines (\n                      \n                      ) regarding the care and use of laboratory animals. Clinical trial number: Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"18433"}}